Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Raymond E, Ruszniewski P. New treatments of pancreatic neuroendocrine tumors: why using them? How to use them? Target Oncol 2012;7:91-2. [PMID: 22669625 DOI: 10.1007/s11523-012-0222-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2012] [Accepted: 05/13/2012] [Indexed: 12/18/2022]

For:	Raymond E, Ruszniewski P. New treatments of pancreatic neuroendocrine tumors: why using them? How to use them? Target Oncol 2012;7:91-2. [PMID: 22669625 DOI: 10.1007/s11523-012-0222-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2012] [Accepted: 05/13/2012] [Indexed: 12/18/2022]

Number	Cited by Other Article(s)
1	Raymond E, Dreyer C, Faivre S. Targeting neuroendocrine tumor: mixing standard options with novel therapies. Target Oncol 2012;7:151-2. [PMID: 22918794 DOI: 10.1007/s11523-012-0231-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Accepted: 08/10/2012] [Indexed: 01/10/2023] Abstract Collapse Key Words Collapse MESH Headings Antineoplastic Agents/therapeutic use Antineoplastic Agents, Alkylating/therapeutic use Combined Modality Therapy/methods Dacarbazine/analogs & derivatives Dacarbazine/therapeutic use Disease Progression Drug Resistance, Neoplasm Humans Indoles/therapeutic use Medical Oncology/methods Neoplasm Metastasis Neuroendocrine Tumors/drug therapy Neuroendocrine Tumors/surgery Neuroendocrine Tumors/therapy Pancreatic Neoplasms/drug therapy Pancreatic Neoplasms/surgery Pancreatic Neoplasms/therapy Pyrroles/therapeutic use Sunitinib Temozolomide Treatment Outcome Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Raymond E, Dreyer C, Faivre S. Targeting neuroendocrine tumor: mixing standard options with novel therapies. Target Oncol 2012;7:151-2. [PMID: 22918794 DOI: 10.1007/s11523-012-0231-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Accepted: 08/10/2012] [Indexed: 01/10/2023]